Trustmark National Bank Trust Department Purchases 1,068 Shares of Cardinal Health, Inc. (NYSE:CAH)

Trustmark National Bank Trust Department increased its position in Cardinal Health, Inc. (NYSE:CAH) by 4.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 23,481 shares of the company’s stock after buying an additional 1,068 shares during the period. Trustmark National Bank Trust Department’s holdings in Cardinal Health were worth $2,777,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. Cyrus J. Lawrence LLC bought a new position in shares of Cardinal Health in the fourth quarter worth about $26,000. Promus Capital LLC bought a new position in Cardinal Health in the 4th quarter worth approximately $30,000. Lee Danner & Bass Inc. purchased a new stake in Cardinal Health during the 4th quarter valued at approximately $35,000. Kentucky Trust Co purchased a new stake in Cardinal Health during the 4th quarter valued at approximately $41,000. Finally, HHM Wealth Advisors LLC raised its position in shares of Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after buying an additional 144 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on CAH. Argus set a $148.00 target price on shares of Cardinal Health in a research note on Tuesday, February 4th. Mizuho raised their price objective on Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a research report on Monday, March 31st. Bank of America lifted their target price on Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday. Wells Fargo & Company raised their price target on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, Morgan Stanley lifted their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research note on Friday, January 31st. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $140.86.

Cardinal Health Stock Up 2.1 %

Shares of CAH opened at $131.65 on Monday. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $139.50. The company has a market cap of $31.80 billion, a PE ratio of 24.56, a P/E/G ratio of 1.49 and a beta of 0.61. The business has a fifty day moving average of $129.33 and a 200 day moving average of $122.48.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.54%. Cardinal Health’s payout ratio is 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.